Autoimmune gastritis studies and gastric cancer: True renaissance or bibliometric illusion

doi:10.3748/wjg.v30.i32.3783

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 32

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7939)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

167

HTML

5572

Tables (1-1)

475

Sum=6214

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

241

Download

645

Sum=886

Publishing Process of This Article

Item

Count

Browse

124

Download

484

Sum=608

Aug 28, 2024 (publication date) through Feb 16, 2026

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastroenterol. Aug 28, 2024; 30(32): 3783-3790
Published online Aug 28, 2024. doi: 10.3748/wjg.v30.i32.3783

Autoimmune gastritis studies and gastric cancer: True renaissance or bibliometric illusion

Vasily Isakov

Vasily Isakov, Department of Gastroenterology and Hepatology, Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow 115446, Russia

Author contributions: Isakov V contributed to the writing, and editing the manuscript, and review of literature.

Supported by Ministry of Science and High Education of Russia, No. FGMF-2022-0005.

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Corresponding author: Vasily Isakov, AGAF, MD, PhD, Chief, Professor, Department of Gastroenterology and Hepatology, Federal Research Center of Nutrition, Biotechnology and Food Safety, 21 Kashirskoye Shosse, Moscow 115446, Russia. vasily.isakov@gmail.com

Received: June 8, 2024
Revised: August 8, 2024
Accepted: August 13, 2024
Published online: August 28, 2024
Processing time: 79 Days and 18.5 Hours

Core Tip

Core Tip: Autoimmune gastritis (AIG) is associated with a lower risk of gastric cancer than expected due to the low prevalence of precancerous lesions. In contrast, the risk of type 1 neuroendocrine tumors (Type1-NETs) is high and always co-exists with anti-parietal cell antibodies and extensive oxyntic atrophy. Endoscopic surveillance is needed for the early diagnosis and curative treatment of Type1-NETs. The progression of gastric atrophy during the course of AIG leads to hypochlorhydria and subsequent changes in the gastric microbiome. Among the numerous species harboring the stomach in patients with atrophic AIG, Streptococcus anginosus is one of the key candidates to be a driver of gastric carcinogenesis in post- Helicobacter pylori era.